Back to Authors

Farris, Joseph D

Mayo Clinic

Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Citations 2

Movement Disorder Following Hypoglycemic Encephalopathy in Mitochondrial 3-Hydroxy-3-methylglutaryl-CoA Synthase-2 (mHS) Deficiency
Osundiji, Mayowa A. , Chen, Alicia , Farris, Joseph , Farris, Joseph D, Osundiji, Mayowa Azeez , Dhamija, Radhika

Annals of Internal Medicine: Clinical Cases | August 5, 2025 | Volume: 4 | Issue: 8 | Pages: No page available

10.7326/aimcc.2025.0080 Get It

Expanding Upon Genomics in Rare Diseases: Epigenomic Insights
Tan, Jia W. , Blake, Emily J. , Farris, Joseph , Klee, Eric W. , Farris, Joseph D, Klee, Eric W , Tan, Jia Wen

International Journal of Molecular Sciences | December 27, 2024 | Volume: 26 | Issue: 1 | Pages: 135

10.3390/ijms26010135 Get It

DNA methylation is an essential epigenetic modification that plays a crucial role in regulating gene expression and maintaining genomic stability. With the advancement in sequencing technology, methylation studies have provided valuable insights into the diagnosis of rare diseases through the various identification of episignatures, epivariation, epioutliers, and allele-specific methylation. However, current methylation studies are not without limitations. This mini-review explores the current understanding of DNA methylation in rare diseases, highlighting the key mechanisms and diagnostic potential, and emphasizing the need for advanced methodologies and integrative approaches to enhance the understanding of disease progression and design more personable treatment for patients, given the nature of rare diseases.